Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Colorectal Neoplasms

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 36 articles: HTML format Text format

Single Articles

January 2012
1. SUN DF , Gao ZH, Liu HP, Yuan Y, et al
   Sphingosine 1-phosphate antagonizes the effect of all-trans retinoic acid (ATRA) in a human colon cancer cell line by modulation of RARbeta expression.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. LAMPROPOULOS P , Zizi-Sermpetzoglou A, Rizos S, Kostakis A, et al
   TGF-beta signalling in colon carcinogenesis.
   Cancer Lett. 2012;314:1-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. COPPEDE F
   Epigenetic biomarkers of colorectal cancer: focus on DNA methylation.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. DAI M , Xu X, Song J, Fu S, et al
   Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice.
   Cancer Lett. 2011;312:189-96.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MIYATANI T , Kurita N, Utsunomiya T, Iwata T, et al
   Platelet-derived endothelial cell growth factor/thymidine phosphorylase inhibitor augments radiotherapeutic efficacy in experimental colorectal cancer.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
6. ZHAO L , Bai C, Shao Y, Guan M, et al
   A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
   Cancer Lett. 2011;310:134-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. HE H , Huynh N, Liu KH, Malcontenti-Wilson C, et al
   P-21 Activated Kinase 1 Knockdown Inhibits beta-Catenin Signalling and Blocks Colorectal Cancer Growth.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. VICINUS B , Rubie C, Faust SK, Frick VO, et al
   miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. ZHU Y , Michelle Luo T, Jobin C, Young HA, et al
   Gut microbiota and probiotics in colon tumorigenesis.
   Cancer Lett. 2011;309:119-27.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. LEE J , Lee J, Yu H, Choi K, et al
    Differential dependency of human cancer cells on vascular endothelial growth factor-mediated autocrine growth and survival.
    Cancer Lett. 2011;309:145-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. SERRANO-HERAS G , Dominguez-Berzosa C, Collantes E, Guadalajara H, et al
    NIH-3T3 fibroblasts cultured with plasma from colorectal cancer patients generate poorly differentiated carcinomas in mice.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. LUO H , Yang Y, Huang F, Li F, et al
    Selenite induces apoptosis in colorectal cancer cells via AKT-mediated inhibition of beta-catenin survival axis.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. SUN NF , Meng QY, Tian AL, Hu SY, et al
    Nanoliposome-mediated FL/TRAIL double-gene therapy for colon cancer: In vitro and in vivo evaluation.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. WANG F , Zhang P, Ma Y, Yang J, et al
    NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
15. DIA VP , Gonzalez de Mejia E
    Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to alpha(5)beta(1) integrin and suppresses FAK/ERK/NF-kappaB signaling.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. LIANG H , Zhong Y, Zhou S, Peng L, et al
    Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. BALOGLU H , Yigit N
    Stromal cells do not share KRAS mutations that the epithelial component harbors in colorectal carcinomas.
    Cancer Lett. 2011;308:118-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. ZHANG H , Zhang S, He H, Zhao W, et al
    RasGAP-derived peptide 38GAP potentiates the cytotoxicity of cisplatin through inhibitions of Akt, ERK and NF-kappaB in colon carcinoma HCT116 cells.
    Cancer Lett. 2011;308:62-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
19. ALDEA M , Clofent J, Nunez de Arenas C, Chamorro M, et al
    Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
20. TIWARI AK , Crawford SE, Radosevich A, Wali RK, et al
    Neo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis.
    Cancer Lett. 2011;306:205-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HIBI K , Goto T, Shirahata A, Saito M, et al
    Detection of TFPI2 methylation in the serum of colorectal cancer patients.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. HUI X , Chen H, Zhang S, Ma X, et al
    Antitumor activities of recombinant human interferon (IFN)-lambda1 in vitro and in xenograft models in vivo for colon cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. YAP YH , Say YH
    Resistance against apoptosis by the cellular prion protein is dependent on its glycosylation status in oral HSC-2 and colon LS 174T cancer cells.
    Cancer Lett. 2011;306:111-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
24. LIANG D , Qin Y, Zhao W, Zhai X, et al
    S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. MATSUDA Y , Ishiwata T, Yamahatsu K, Kawahara K, et al
    Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: A potential therapeutic target in colorectal cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. WANG J , Wu J, Hong J, Chen R, et al
    PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin alphavbeta6.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. LI XB , Jiao S, Sun H, Xue J, et al
    The orphan nuclear receptor EAR2 is overexpressed in colorectal cancer and it regulates survivability of colon cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. XU Y , Li J, Zuo Y, Deng J, et al
    SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. HEBELS DG , Sveje KM, de Kok MC, van Herwijnen MH, et al
    N-nitroso compound exposure-associated transcriptomic profiles are indicative of an increased risk for colorectal cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
30. TANG MC , Chan LC, Yeh YC, Chen CY, et al
    Thymosin beta 4 induces colon cancer cell migration and clinical metastasis via enhancing ILK/IQGAP1/Rac1 signal transduction pathway.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. YE L , Zhang B, Seviour EG, Tao KX, et al
    Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
32. XU R , Nakano K, Iwasaki H, Kumagai M, et al
    Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. CANTERO-MUNOZ P , Urien MA, Ruano-Ravina A
    Efficacy and safety of intraoperative radiotherapy in colorectal cancer: A systematic review.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
34. LIU M , Lang N, Chen X, Tang Q, et al
    miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
    Cancer Lett. 2011;301:151-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. LI J , Chen Y, Zhao J, Kong F, et al
    miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
36. ZHANG C , Wu R, Zhu H, Hu YZ, et al
    Enhanced anti-tumor activity by the combination of TRAIL/Apo-2L and combretastatin A-4 against human colon cancer cells via induction of apoptosis in vitro and in vivo.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: